Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
STRATEC Biomedical AG (GB:0RAR)
LSE:0RAR
STRATEC Biomedical (0RAR) Share Price & Analysis
1 Followers
0RAR Stock Chart & Stats
Day’s Range€0 - €0
52-Week Range€36.05 - €52.20
Previous Close€41
Volume0.00
Average Volume (3M)1.94K
Market Cap
€504.47M
Enterprise Value€567.55M
Total Cash (Recent Filing)€24.07M
Total Debt (Recent Filing)€87.15M
Price to Earnings (P/E)41.0
Beta0.69
Next Earnings
Aug 09, 2024EPS Estimate
€0.33Last Dividend Ex-Date
May 20, 2024Dividend Yield1.34%
Share Statistics
EPS (TTM)1.00
Shares Outstanding12,157,841
10 Day Avg. Volume5,353
30 Day Avg. Volume1,944
Standard Deviation0.10
R-Squared0.00029
Alpha0.02
Financial Highlights & Ratios
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)N/A
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
€44.67Price Target Upside8.95% Upside
Rating ConsensusHold
Number of Analyst Covering3
STRATEC Biomedical News
PremiumGlobal Markets
German Market Update: Three Shares to Buy TodayOptions Prices
Currently, No data available
---
Ownership Overview
0.00%
Insiders
11.60% Mutual Funds
1.99% Other Institutional Investors
86.41% Public Companies and
Individual Investors
0RAR FAQ
What was STRATEC Biomedical AG’s price range in the past 12 months?
STRATEC Biomedical AG lowest share price was €36.05 and its highest was €52.20 in the past 12 months.
What is STRATEC Biomedical AG’s market cap?
Currently, no data Available
When is STRATEC Biomedical AG’s upcoming earnings report date?
STRATEC Biomedical AG’s upcoming earnings report date is Aug 09, 2024 which is in 14 days.
How were STRATEC Biomedical AG’s earnings last quarter?
STRATEC Biomedical AG released its earnings results on Apr 26, 2024. The company reported €0.07 earnings per share for the quarter, beating the consensus estimate of N/A by €0.07.
Is STRATEC Biomedical AG overvalued?
According to Wall Street analysts STRATEC Biomedical AG’s price is currently Undervalued.
Does STRATEC Biomedical AG pay dividends?
STRATEC Biomedical AG pays a Annually dividend of €0.55 which represents an annual dividend yield of 1.34%. See more information on STRATEC Biomedical AG dividends here
What is STRATEC Biomedical AG’s EPS estimate?
STRATEC Biomedical AG’s EPS estimate is €0.33.
How many shares outstanding does STRATEC Biomedical AG have?
STRATEC Biomedical AG has 12,157,841 shares outstanding.
What happened to STRATEC Biomedical AG’s price movement after its last earnings report?
STRATEC Biomedical AG reported an EPS of €0.07 in its last earnings report, beating expectations of N/A. Following the earnings report the stock price went up 1.367%.
Which hedge fund is a major shareholder of STRATEC Biomedical AG?
Currently, no hedge funds are holding shares in GB:0RAR
---
STRATEC Biomedical Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Hold
Average Price Target:
€44.67 (8.95% Upside)
€44.67 (8.95% Upside)
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Fundamentals
Return on Equity
5.29%
Trailing 12-Months
Asset Growth
10.27%
Trailing 12-Months
Company Description
STRATEC Biomedical AG
Stratec SE designs and manufactures automated analyzer systems for laboratory data management and solutions for molecular diagnostic sample preparation and stabilization. Its business segments are Instrumentation, Diatron, Smart Consumables, and Others. The company generates maximum revenue from the Instrumentation segment. Its Instrumentation segment is engaged in designing and manufacturing automated analyzer systems for the clinical diagnostics and biotechnology customers. The Diatron segment comprises the business with systems, system components, consumables and tests in the low throughput hematology and clinical chemistry segment. Its Smart Consumables segment is engaged in developing and selling scientific materials, such as nucleic acid purification.
---
0RAR Stock 12 Month Forecast
Average Price Target
€44.67
▲(8.95% Upside)
Technical Analysis
---